Хайлтын үр дүнгүүд - Jim Cassidy

  • 15-н 1 - 15 үр дүнгүүдийг харуулж байна
Үр дүнг сайжруулах
  1. 1
    The Evolution of Fluoropyrimidine Therapy: From Intravenous to Oral

    The Evolution of Fluoropyrimidine Therapy: From Intravenous to Oral -н Paulo M. Hoff, Jim Cassidy, Hans‐Joachim Schmoll

    Хэвлэсэн 2001
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  2. 2
    Striking the right balance in colorectal cancer care--a qualitative study of rural and urban patients

    Striking the right balance in colorectal cancer care--a qualitative study of rural and urban patients -н Norma Bain, Neil Campbell, Lewis Ritchie, Jim Cassidy

    Хэвлэсэн 2002
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  3. 3
    Hypoxia-inducible factor 1 alpha is required for the tumourigenic and aggressive phenotype associated with Rab25 expression in ovarian cancer

    Hypoxia-inducible factor 1 alpha is required for the tumourigenic and aggressive phenotype associated with Rab25 expression in ovarian cancer -н Natividad Gomez-Roman, Neha M. Sahasrabudhe, Fiona McGregor, Anthony J. Chalmers, Jim Cassidy, Jane A. Plumb

    Хэвлэсэн 2016
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  4. 4
    A phase 1 trial of recombinant human IL-21 in combination with cetuximab in patients with metastatic colorectal cancer

    A phase 1 trial of recombinant human IL-21 in combination with cetuximab in patients with metastatic colorectal cancer -н N. Steele, A Anthony, Mark Saunders, B. Esmarck, E. Ehrnrooth, Paul E.G. Kristjansen, Annsofi Nihlén, L T Hansen, Jim Cassidy

    Хэвлэсэн 2012
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  5. 5
    Efficacy of capecitabine versus 5-fluorouracil in colorectal and gastric cancers: a meta-analysis of individual data from 6171 patients

    Efficacy of capecitabine versus 5-fluorouracil in colorectal and gastric cancers: a meta-analysis of individual data from 6171 patients -н Jim Cassidy, Leonard B. Saltz, Chris Twelves, Eric Van Cutsem, Paulo M. Hoff, Yoon‐Koo Kang, Jasmine Saini, Frank Gilberg, David Cunningham

    Хэвлэсэн 2011
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  6. 6
    Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: Data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, C-06, C-07 and C89803

    Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: Dat... -н Daniel J. Sargent, Qian Shi, Greg Yothers, Eric Van Cutsem, Jim Cassidy, Leonard B. Saltz, Norman Wolmark, Brian M. Bot, Axel Grothey, Marc Buyse, Aimery de Gramont

    Хэвлэсэн 2011
    Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  7. 7
    Efficacy of Oxaliplatin Plus Capecitabine or Infusional Fluorouracil/Leucovorin in Patients With Metastatic Colorectal Cancer: A Pooled Analysis of Randomized Trials

    Efficacy of Oxaliplatin Plus Capecitabine or Infusional Fluorouracil/Leucovorin in Patients With Metastatic Colorectal Cancer: A Pooled Analysis of Randomized Trials -н Hendrik‐Tobias Arkenau, Dirk Arnold, Jim Cassidy, Eduardo Díaz‐Rubio, Jean‐Yves Douillard, Howard S. Höchster, Andrea Martoni, Axel Grothey, Axel Hinke, Wolff Schmiegel, Hans‐Joachim Schmoll, Rainer Porschen

    Хэвлэсэн 2008
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  8. 8
    Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer

    Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer -н Jim Cassidy, Stephen Clarke, Eduardo Díaz‐Rubio, Werner Scheithauer, Arié Figer, Ralph Wong, Sheryl Koski, Mikhail Lichinitser, Tsai‐Shen Yang, Fernando Rivera, Félix Couture, Florin Sirzén, Leonard B. Saltz

    Хэвлэсэн 2008
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  9. 9
    Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

    Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study -н Leonard B. Saltz, Stephen Clarke, Eduardo Díaz‐Rubio, Werner Scheithauer, Arié Figer, Ralph Wong, Sheryl Koski, Mikhail Lichinitser, Tsai‐Shen Yang, Fernando Rivera, Félix Couture, Florin Sirzén, Jim Cassidy

    Хэвлэсэн 2008
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  10. 10
    XELOX (Capecitabine Plus Oxaliplatin): Active First-Line Therapy for Patients With Metastatic Colorectal Cancer

    XELOX (Capecitabine Plus Oxaliplatin): Active First-Line Therapy for Patients With Metastatic Colorectal Cancer -н Jim Cassidy, Josep Tabernero, Chris Twelves, René Brunet, Charles Butts, Thierry Conroy, Filippo de Braud, Arié Figer, Johannes Grossmann, Noriaki Sawada, Patrick Schöffski, Alberto Sobrero, Eric Van Cutsem, Eduardo Díaz‐Rubio

    Хэвлэсэн 2004
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  11. 11
    First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous5-fluorouracil/leucovorin

    First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous5-fluorouracil/leucovorin -н Jim Cassidy, Chris Twelves, Eric Van Cutsem, Paulo M. Hoff, Emilio Bajetta, Michael Boyer, R. Bugat, Ulrich Bürger, A. Garin, Ullrich Graeven, J. McKendrick, Jean A. Maroun, John L. Marshall, B Osterwalder, G. Pérez-Manga, R. Rosso, P. Rougier, Richard L. Schilsky

    Хэвлэсэн 2002
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  12. 12
    Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial

    Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial -н Werner Scheithauer, J McKendrick, S. Begbie, Markus Borner, W. Ivon Burns, Howard A. Burris, Jim Cassidy, Duncan I. Jodrell, P. Koralewski, E.L. Levine, Norbert Marschner, Jean A. Maroun, Pilar García‐Alfonso, Jerzy Tujakowski, Guy van Hazel, A. Wong, J. Załuski, Chris Twelves

    Хэвлэсэн 2003
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  13. 13
    Potential Regional Differences for the Tolerability Profiles of Fluoropyrimidines

    Potential Regional Differences for the Tolerability Profiles of Fluoropyrimidines -н Daniel G. Haller, Jim Cassidy, Stephen Clarke, David Cunningham, Eric Van Cutsem, Paulo M. Hoff, Mace L. Rothenberg, Leonard B. Saltz, Hans‐Joachim Schmoll, Carmen J. Allegra, Joseph R. Bertino, Jean-Yves Douillard, Bengt Gustavsson, G. Milano, Michael J. OʼConnell, Youcef M. Rustum, Josep Tabernero, Frank Gilberg, Florin Sirzén, Chris Twelves

    Хэвлэсэн 2008
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  14. 14
    Capecitabine as Adjuvant Treatment for Stage III Colon Cancer

    Capecitabine as Adjuvant Treatment for Stage III Colon Cancer -н Chris Twelves, A. Wong, Marek P. Nowacki, Markus Abt, Howard A. Burris, Alfredo Carrato, Jim Cassidy, Andrés Cervantes, Jan Fagerberg, Vassilis Georgoulias, Fares Husseini, Duncan I. Jodrell, P. Koralewski, H. Kröning, Jean A. Maroun, Norbert Marschner, Joseph McKendrick, Marek Pawlicki, Riccardo Rosso, Johannes Schüller, Jean‐François Seitz, Borut S̆tabuc, Jerzy Tujakowski, Guy van Hazel, J. Załuski, Werner Scheithauer

    Хэвлэсэн 2005
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  15. 15
    3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial

    3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial -н Timothy Iveson, Rachel Kerr, Mark Saunders, Jim Cassidy, Niels Henrik Holländer, Josep Tabernero, Andrew Haydon, Bengt Glimelius, Andrea Harkin, Karen Allan, John McQueen, Claire Scudder, Kathleen Boyd, Andrew Briggs, Ashita Waterston, Louise Medley, Charles B. Wilson, Richard Ellis, Sharadah Essapen, A.S. Dhadda, Mark Harrison, Stephen Falk, Sherif Raouf, Charlotte Rees, Rene K Olesen, David Propper, John Bridgewater, Ashraf Azzabi, David Farrugia, Andrew Webb, David Cunningham, Tamas Hickish, Andrew Weaver, Simon Gollins, Harpreet Wasan, James Paul

    Хэвлэсэн 2018
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:

Хайх хэрэгслүүд: